Table 1.
Characteristic | Control Subjects∗ | COPD Subjects |
||
---|---|---|---|---|
Total | Mild Obstruction† | Moderate/Severe Obstruction† | ||
n | 55 | 62 | 30 | 32 |
Baseline FEV1 (mean ± SD) | 2.49 ± 0.59 | 1.28 ± 0.57 | 1.70 ± 0.45 | 0.89 ± 0.34 |
Age, yr (mean ± SD) | 67.5 ± 5.3 | 65.4 ± 7.4 | 67.1 ± 6.0 | 63.8 ± 8.3 |
Sex (M/F) | 24/31 | 26/36 | 13/17 | 13/19 |
Months of follow-up (mean ± SD) | 35.1 ± 10.9‡ | 26.3 ± 14.2‡ | 28.1 ± 11.7 | 24.6 ± 13.2 |
FEV1 = forced expiratory volume in 1 second.
Adapted from Am J Respir Crit Care Med.6
FEV1 at baseline >80% of predicted.
Baseline pulmonary function tests included spirometry; mild obstruction was defined as an enrollment FEV1 ≥50% and <80% predicted, and moderate/severe obstruction was defined as an enrollment FEV1 <50% predicted.
P <0.001.